ImageneBio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ImageneBio, Inc. (IMA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 66.02 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-10
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 206.78K shares.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 1.14M shares.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-12-31 was 484.86K shares.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was 491.00K shares.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 66.02K shares, a 96.31% decline from fiscal 2024.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 1.79M shares, a 46.82% increase from fiscal 2023.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 1.22M shares, a 38.64% increase from fiscal 2022.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 878.08K shares, a 1709.66% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 66.02K shares 10-K · filed 2026-03-10 | |||
| 2025-06-30 | 206.78K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | 1.35M shares 10-Q · filed 2025-07-24 | 1.83M shares derived: sum of 3 quarters · filed 2025-07-24 | 2.32M shares derived: sum of 4 quarters · filed 2025-07-24 |
| 2025-03-31 | 1.14M shares 10-Q · filed 2025-05-08 | 1.62M shares derived: sum of 2 quarters · filed 2025-05-08 | 2.11M shares derived: sum of 3 quarters · filed 2025-05-08 | |
| 2024-12-31 | 484.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 975.86K shares derived: sum of 2 quarters · filed 2025-03-06 | 1.79M shares 10-K · filed 2025-03-06 | |
| 2024-09-30 | 491.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 1.30M shares 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | 811.52K shares 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | 1.22M shares 10-K · filed 2024-03-12 | |||
| 2022-12-31 | 158.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 409.21K shares derived: sum of 2 quarters · filed 2023-03-14 | 584.45K shares derived: sum of 3 quarters · filed 2023-03-14 | 878.08K shares 10-K · filed 2023-03-14 |
| 2022-09-30 | 250.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 425.53K shares derived: sum of 2 quarters · filed 2022-11-07 | 719.17K shares 10-Q · filed 2022-11-07 | 745.50K shares derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | 175.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 468.87K shares 10-Q · filed 2022-08-11 | 495.20K shares derived: sum of 3 quarters · filed 2022-08-11 | 500.54K shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 293.64K shares 10-Q · filed 2022-05-12 | 319.97K shares derived: sum of 2 quarters · filed 2022-05-12 | 325.31K shares derived: sum of 3 quarters · filed 2022-05-12 | |
| 2021-12-31 | 26.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 31.68K shares derived: sum of 2 quarters · filed 2022-03-17 | 48.52K shares 10-K · filed 2022-03-17 | |
| 2021-09-30 | 5.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 22.19K shares 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | 16.85K shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |